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In the present studies, a novel compound with potent anti-tumor activity from Ciona intestinalis L. was puriﬁed by acetone
fractionation, ultraﬁltration, gel chromatography and High Performance Liquid Chromatography. The molecular weight of the
highly puriﬁed compound, designated CI431, was 431Da as determined by HPLC-MS analysis. CI431 exhibited signiﬁcant
cytotoxicity to several cancer cell types. However, only a slight inhibitory eﬀect was found when treating the benign human
liver cell line BEL-7702 with the compound. To explore its mechanism against hepatocellular carcinoma, BEL-7402 cells were
treated with CI431 in vitro. We found that CI431 induced apoptotic death in BEL-7402 cells in a dose- and time-dependent
manner. Cell cycle analysis demonstrated that CI431 caused cell cycle arrest at the G2/M phase, and a sub-G1 peak appeared after
24h. The mitochondrial-mediated pathway was implicated in this CI431-induced apoptosis as evidenced by the disruption of
mitochondrial membrane potential. The results suggest that the CI431 induces apoptosis in BEL-7402 human hepatoma cells by
intrinsic mitochondrial pathway.
1.Introduction
It is now clear that the oceans are not only home to a tre-
mendous diversity of species but that their inhabitants pro-
duce also a wealth of natural products [1]. Since the 1950s,
many structurally diverse natural products with astounding
bioactivities have been discovered from marine organisms
[2]. These compounds are mainly isolated from sessile an-
imals, such as sponges, tunicates, corals, mollusks, and bry-
ozoans [3, 4].
Among sessile animals, tunicates have received the most
attention. More commonly known as Ascidiacea, members
of the class Ascidiacea (Ascidians) are the most highly in-
vestigated tunicates, since they present a benthonic stage in
their life, making their collection easier. The chemistry of
ascidians has become one of the most active ﬁelds of marine
natural products; it has been amply demonstrated that these
seacreaturesareproliﬁcproducersofunusualstructureswith
signiﬁcant bioactivities. Most of these products fall within
the area of cancer therapy [5], and a signiﬁcant number of
ascidian-derived compounds have entered into preclinical
and clinical trials as antitumor agents [3, 6].
Didemnin B, is perhaps the most studied marine natural
product. This cyclic peptide was isolated from the Caribbean
tunicate Trididemnum solidum [7]. Early investigation into
the bioactivity of this compound revealed its strong antipro-
liferative eﬀects in vitro against a variety of human tumor
cell lines. It was developed by NCI and went through phase
II clinical trials but was withdrawn because it proved to be
too toxic. Although didemnin B was never carried into Phase
III trials, activity focused on developing the compound as
a potential cancer treatment helped pave the way for the
rest of the marine-derived products following it into the de-
velopmentpipeline.Aplidine[8],Vitilevuamide[9],Diazon-
amide [10], and ET-743 [11], all of them were compounds
with eﬃcient antitumor activity isolated from Ascidians.
Hepatocellular carcinoma (HCC) is the ﬁfth most com-
mon cancer [12], with a 5-year survival rate of less than 5%
and is the fourth leading cause of cancer death worldwide2 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Elution patterns on column chromatography. The fraction of acetone precipitation was applied to Sephadex G25 column (a).
The active fraction from Sephadex G25 chromatography was applied to P2 column (b). The active fraction from P2 was further puriﬁed by
high-performance liquid chromatography (c). The arrow indicates the active component during the puriﬁcation.
[13–15]. Its incidence has been increasing over the past
few decades in some areas such as Europe, USA, and East
Asia [16, 17]. Despite the high mortality and frequency
of this cancer, surgical resection is an available option for
only a small proportion of patients because metastases are
often present when the cancer is discovered. In addition,
because of the inherent chemotherapy-resistant nature of
HCC,systemiccytotoxicchemotherapyagentsareminimally
eﬀective at improving patient survival [18]. Thus, novel
strategies and agents, which have greater targeting on HCC
butlowerto xicityfornormallivercells,areseenasadirection
of enormous potential.
Previous studies have shown that several agents derived
from Ascidiae can induce the apoptosis of many cancer cells
[5]. However, Ciona intestinalis L., a selected species in the
present study, has not been studied for its anticancer eﬀects.
Therefore, we attempted to investigate the growth-inhib-
itory and apoptotic eﬀects of components from Ciona
intestinalis L. against human liver cancer cells. A bioguid-
ed isolation was performed to purify the active components
from the species. We found that a component, CI431, was a
potent inhibitor against human hepatoma Bel-7402 cells and
may be developed as a novel class of anticancer agents.
2.SubjectsandMethods
2.1. Materials. Ciona intestinalis L. was obtained from the
Xunshan Fishery Company of Rongcheng, China. The an-
imals were identiﬁed by professor Fuhua-li at Institute of
Oceanology, Chinese Academy of Sciences. The human he-
patocellular cancer BEL-7402, human colorectal cancer
HCT116, human cervical cancer Hela cells as well as human
lung adenocarcinoma A549, breast cancer MCF-7, and
human benign liver cell BEL-7702 cells were obtained from
American Type Culture Collection.
2.2. Extraction and Puriﬁcation of the Compound from Ciona
intestinalisL. Brieﬂy,50kgfreshC.intestinalisweresmashed
and incubated at 70◦C for 30min and were then centrifuged
at 8,000rpm for 30min. Next, the supernatants were added
to 3 volumes of acetone at 4◦C for 12h and were cen-
trifuged at 10,000rpm for 30min once more. The acetone
supernatants were collected and then were disposed through
a 5kDa ultraﬁltration membrane (Millipore, USA). The
residue with size <5kDa was lyophilized and dissolved in
a small amount of distilled water. The prepared extractionEvidence-Based Complementary and Alternative Medicine 3
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Figure 2: CI431 inhibited the growth of several types of cancer
cells. Human hepatoma BEL-7402, human colon cancer HCT116,
human breast cancer MCF-7, human cervical cancer Hela cells, and
human lung adenocarcinoma A549 as well as human benign liver
cell BEL-7702 cells were incubated in the absence or presence of
certain concentrations of CI431 for 48h at 37◦C. MTT assay was
performed to determine the growth inhibition of diﬀerent cancer
cells and benign BEL-7702 cells by CI431. The experiments were
performed more than three times.
solution was applied to a Sephadex-G25 column and eluted
with distilled water.
All of the fractions were collected and analyzed for cyto-
toxicity by MTT assay. The active fraction was lyophilized
and loaded to a P2 Gel (Bio-Rad Laboratories, Inc) column.
The column was eluted with distilled water. The active frac-
tion was pooled and subjected to reverse-phase liquid chro-
matography on a C18 column (Agilent C18 4.6 × 250mm)
using an Agilent apparatus. The chromatography was per-
formed at a ﬂow rate of 0.5mL/min, using 0.1% TFA as
solvent A and 99.9% acetonitrile containing 0.1% TFA as
solvent B. The gradient was 10–60% of solvent B for 50min.
The elution proﬁle was monitored by online measurement
of the absorbance at 214 and 280nm. The fractions were
p o o l e da n df r e e z ed r i e d .A l lo ft h ef r a c t i o n sw e r ec o l l e c t e d
and analyzed by MTT assay.
2.3. Cell Culture. The carcinoma cells BEL-7402, Hela,
HCT116, and benign liver cell BEL-7702 were cultured in
RPMI-1640 medium. The MCF-7 cell lines were cultured in
DMEM medium. The A549 cell lines were cultured in F12
medium. All cells were incubated in media supplemented
with 10% fetal bovine serum in a humidiﬁed atmosphere
containing 5% CO2 at 37◦C. The media and sera were
purchased from Sigma Chemical.
2.4. Assessment of Cytotoxicity. The inhibitory eﬀects of the
antitumor agents on the growth of cancer cells as well as
benign cells BEL-7702 were assessed in vitro by MTT assay
[19]. Four thousand cells per well were seeded into a 96-well
microplate. Cells were cultured in 180μL media of RPMI-
1640, 12K, or DMEM for 24h. The puriﬁed compound with
diﬀerent concentrations was added to the medium. After
48h, MTT solution (50μL, 0.5mg/mL) was added into each
well, and the cells were incubated for another 4h. After
adding 150μL DMSO to each aspirated well, the plate was
gently agitated until the color reaction was uniform. The
OD590 was determined by a microplate reader (Bio-Tek
Instruments, USA) with subtraction of background absorb-
ance [20].
2.5. CI431-Induced Morphological Changes of BEL-7402 Cells.
Morphological alterations of BEL-7402 cells after CI431
treatment were investigated using phase contrast microscopy
and SEM. The cells were seeded and cultured in 96-well
plates, as described above. After incubation with 50μg/mL
CI431, the morphology of cells was observed under the
CKX41 phase contrast microscopy (Olympus, Japan) and
photographed at 0, 12, and 24h, respectively. In the SEM
experiment, BEL-7402 cells were grown onto poly-L-lysine-
coated coverslips in 6-well plates for 24h to allow ﬁrm
attachment. Then, they were treated with 50μg/mL CI431
and incubated for 0, 12, and 24h. The medium containing
CI431 was removed, and subsequently the cells were ﬁxed in
glutaraldehyde. After ﬁxation overnight at 4◦C, the coverslip
was dehydrated in ethanol and dried in a critical point dryer.
Cells on coverslip were coated with gold and analyzed by the
S-3400N SEM (Hitachi, Japan).
2.6. DAPI (4 -6-diamidino-2-phenylindole) Staining. The
cells BEL-7402 were grown onto poly-L-lysine-coated cov-
erslips in 6-well plates and treated with CI431 as described
above for the SEM assay. Then the medium containing
CI431 was removed, and subsequently the cells were ﬁxed
in paraformaldehyde. After ﬁxation overnight at 4◦C, the
coverslips were stained with DAPI solution followed by
observation with a ﬂuorescence microscope [21].
2.7. Flow Cytometric Analysis. The cells BEL-7402 were
incubated with 20, 40, and 80μg/mL of CI431 for 24h. The
cells were harvested and ﬁxed in ice-cold 70% (v/v) ethanol
for 24h at 4◦C. After centrifugation, the cell pellet was
resuspended in PBS; the cells were subjected to propidium
iodide (PI) staining and then analyzed by a ﬂow cytometry
(FACSCalibur; BD Biosciences, USA) [22].
2.8. Mitochondrial-Membrane Potential (Δψm). The JC-1
Mitochondrial Apoptosis Detection Kit was used to detect
Δψm disruption. JC-1 is selectively accumulated within
intact mitochondria to form multimer J-aggregates emitting
ﬂuorescence light at 590nm (red) at a higher membrane
potential,andmonomericJC-1emitslightat527nm(green)
at a low membrane potential. Thus, the ﬂuorescence color of
JC-1 represents mitochondrial-membrane potential, which
c a nb ea n a l y z e db yF A C Ss y s t e m[ 23]. According to the
manufacturer’s protocols, cells were seeded in 12-well plates
at a density of 3 × 105 cells/mL and treated with CI431 at
doses of 20, 40, and 80μg/mL for 24h. After treatment with4 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Morphological analysis of BEL-7402 cells induced by CI431. BEL-7402 cells were grown on poly-L-lysine-coated coverslips for
24h to allow ﬁrm attachment and treated with 50μg/mL CI431 for certain time intervals. Cells were ﬁxed on coverslips coated with gold and
analyzed by using the KYKY-2800B SEM. The cells were untreated (a) or treated with CI431 for 12 (b), 18 (c), and 24h (d). The untreated
BEL-7402 cells showed a normal smooth surface. In contrast, the cells treated with CI431 became rounded, and the surface of the cell
membrane was markedly disrupted (Scale bar = 10μm).
CI431 200μL, prewarmed incubation buﬀer containing
0.2μL MitoCapture was added to each well and plates were
incubated for 15min at 37◦Ci na5 %C O 2 incubator. Then,
cells were analyzed by a ﬂuorescence spectrophotometer (F-
4500, HITACHI).
2.9. Statistical Analysis. All experiments were done three
times in triplicate (n = 9), and the results were expressed
as means ± SD (standard deviation). A one-way analysis
of variance (ANOVA) and the Duncan test were used for
multiple comparisons (SPSS program, ver 10.0).
3. Results
3.1. Extraction and Puriﬁcation of the Compound from Ciona
intestinalis L. In order to isolate novel antitumor agents
from Ciona intestinalis L., we developed a puriﬁcation
protocol involving heat-inactivation, acetone precipitation,
ultraﬁltrationconcentration,gelﬁltration,andreverse-phase
chromatography HPCL. Brieﬂy, acetone precipitation, and
ultraﬁltration concentration were carried out to obtain
a pool of antitumor agents as previously described. The frac-
tion obtained after acetone precipitation was concentrated
through a 5kDa ultraﬁltration membrane. The fraction of
acetone precipitation solution, which contained several ma-
jor compounds below 5kDa, showed strong inhibitory ac-
tivity against several tumor cell lines.
The fraction of acetone precipitation compounds was
applied to a Sephadex-G25 column and eluted with distilled
water (Figure 1(a)). The active fractions were further puri-
ﬁed by P2 column (Figure 1(b)). After gel chromatography,
theactivecomponentsweresubmittedtoreverse-phasechro-
matography using a C18 column, and puriﬁed to homo-
geneity (Figure 1(c)). The puriﬁed agent, designated CI431,
was revealed as a single MW by MS.
3.2. Assessment of Cytotoxicity. MTT assays were performed
to investigate the eﬀects of CI431 on the proliferation of
sixcell lines. As shown in Figure 2, CI431 (over 50μg/mL)
had a signiﬁcant growth-inhibiting eﬀect on the ﬁve cancer
cell lines and a slight growth-inhibiting eﬀect on the benign
liver BEL-7702 cell line. Results indicated that CI431 hadEvidence-Based Complementary and Alternative Medicine 5
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Figure 4: DAPI staining assay. The cells BEL-7402 were grown on poly-L-lysine-coated coverslips in 6-well plates and treated with CI431.
After incubation for 24, the cells were stained with DAPI and then observed under the ﬂuorescence microscopy. BEL-7401 cells in the
control medium were stained homogeneously with DAPI (a), whereas treatment with CI431 led to marked chromatin condensation and
nuclear fragmentation together with the appearance of small structures like apoptotic bodies. These observations indicated that the cells
treated with CI431 entered apoptosis (b, c).
a signiﬁcant grow-inhibiting eﬀect on the ﬁve cell lines in
a time-dependent manner (data not shown) and in a dose-
dependent manner (Figure 2). Among these cell lines, the
BEL-7402 cells were much more sensitive than the other cell
lines. From this result, BEL-7402 cells were chosen for the
subsequent experiments.
3.3. CI431-Induced Morphological Changes of BEL-7402 Cells.
T h em o r p h o l o g i cc h a n g e so ft h ec e l lm e m b r a n ew e r e
clearly visualized by SEM. Remarkable alterations of the
cell membrane of BEL-7402 cells were observed after CI431
treatment. The architecture of untreated BEL-7402 cells
displayedatypicalpolygonshape(Figure 3(a)).However,the
morphology of the cells started to change after incubation
with CI431. The cells detached from the substratum, became
spindle shape (Figure 3(b)), and separated from each other
after exposure to CI431 for 12h. Membrane bulge and de-
tachment from cytoplasmic inclusion were observed in 18h
and 24h after CI431 treatment (Figures 3(c) and 3(d)). The
untreated BEL-7402 cells showed a normal smooth surface.
In contrast, the cells treated with CI431 became rounded,
and the surface of the cell membrane was markedly dis-
rupted.
3.4. DAPI (4 -6-diamidino-2-phenylindole) Staining. We
characterized the changes in the nuclear morphology by
staining with DAPI. BEL-7401 cells in the control medium
were stained homogeneously with DAPI, whereas treatment
with CI431 led to marked chromatin condensation and
nuclear fragmentation together with the appearance of small
structures like apoptotic bodies, a biochemical hallmark of
apoptosis. The sizes of CI431-treated BEL-7402 cells in-
creased as compared with those of untreated cells. Double
nucleated cells or giant multinucleated cells can be easily
found. These observations indicated that the cells treated
with CI431 entered apoptosis (Figure 4).
3.5. CI431 Induces Apoptosis and G2/S Phase Arrest in
BEL-7402 Cells. To gain an insight into the antiprolif-
eration mechanism of CI431, the cell cycle distribution
of CI431-treated cells was determined by ﬂow cytometry
analysis. The results showed that CI431 signiﬁcantly induced6 Evidence-Based Complementary and Alternative Medicine
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Figure 5: Eﬀect of CI431 on cell cycle distribution. BEL-7402 cells were seeded at 3 x 104/cm2 in 10-cm dishes and treated with CI431 at 20
(b),40(c)or80μg/mL,respectivelyorwithouttreatment(a).Afterincubationfor24h,cellswerecollectedandtheDNAswerestainedbyPI,
while the RNAs were removed by digestion with RNase A. The DNA contents of the cells were determined with the FACSCalibur cytometer.
The results showed that CI431 signiﬁcantly induced a G2/S phase arrest with a decrease in G0/G1 phase population at 20, 40, and 80μg/mL,
while a dramatic increase of sub-G1 phase (hypodiploid cells) was observed at doses higher than 80μg/mL.
aG 2/S phase arrest with a decrease in G0/G1 phase popu-
lation at 20, 40, and 80μg/mL, while a dramatic increase
of sub-G1 phase (hypodiploid cells) was observed at doses
higher than 80μg/mL (Figure 5).
3.6. Mitochondrial-Membrane Potential (Δψm). To investi-
gate the involvement of the mitochondrial pathway, depolar-
ization of the mitochondrion was analyzed by loading with
JC-1. BEL-7402 were exposed to CI431 at doses of 20, 40,
and 80μg/mL for 24h, and the ratio of green ﬂuorescence
intensity to red ﬂuorescence intensity was used for quantita-
tive analysis of the disruption of Δψm. As shown in Figure 6,
after treatment with CI431, Δψm began to decrease, and the
ratio is 0.61 ± 0.07 (blank), 1.92 ± 0.19 (20μg/mL), 5.08 ±
0.45 (40μg/mL), and 8.28 ± 0.61 (80μg/mL), respectively,
indicating disruption of mitochondrial function.
4. Discussion
Over 17,000 biologically active compounds have been iden-
tiﬁed from marine sources, mainly isolated from sessile an-
imals, such as sponges, tunicates, corals, mollusks, and bry-
ozoans [3, 4]. Many of these substances are potent cytotoxins
that are of great interest for anticancer drug development.
The discovery of new marine drug candidates is a highly
eﬃcient process due to the availability of sophisticatedEvidence-Based Complementary and Alternative Medicine 7
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Figure 6: Cytoﬂuorometric analysis of Δψm BEL-7402 cells were seeded in 12-well plates at a density of 3 × 105 cells/mL and treated
with CI431 at doses of 20, 40, and 80μg/mL for 24h. After treatment with CI431 200μL pre-warmed incubation buﬀer containing 0.2μL
MitoCapture was added to each well and plates were incubated for 15min at 37◦Ci na5 %C O 2 incubator. Then, cells were analyzed by a
Fluorescence Spectrophotometer (F-4500, HITACHI, Japan). After treatment with CI431, Δψm began to decrease, and the ratio of green
ﬂuorescence intensity to red ﬂuorescence intensity was 0.61 ± 0.07 (blank, a), 1.92 ± 0.19 (20μg/mL, b), 5.08 ± 0.45 (40μLgmL, c) and
8.28 ± 0.61 (80μg/mL, d), respectively, indicating disruption of mitochondrial function.
screening, dereplication, and characterization techniques. In
t h i ss t u d y ,w ed e s c r i b ean o v e lp r o t o c o lw h i c ha l l o w se f -
ﬁcient and rapid puriﬁcation of low-molecular weight
marine drug candidates with antitumor activity from Ciona
intestinalis L. We have utilized for their isolation a combina-
tion ofvspace.5ptextraction/puriﬁcation procedures, includ-
ing heating, acetone fractionation, gel chromatography and
high performance liquid chromatography. The proposed
protocol resulted in obtaining homogeneous preparations
of one compound from Ciona intestinalis L. with MW of
431Da, which exhibited strong antitumor activity. The MW
identity of the puriﬁed compound was determined by mass
spectrometry.
We used the MTT assay to test the cytotoxic eﬀects of
CI431 and found that CI431 exhibited potent cytotoxicity
against various types of cancer cell lines in a dose- and
time-dependent manner but inhibited the viability of Bel-
7702, human benign liver cells, very slightly. That CI431 has
opposite eﬀects on tumor cells and normal cells is intriguing.
ThisshowsthatCI431mayhavelittletoxicityfornormalliver
cells. When the cells were stained with diﬀerent concentra-
tions of CI431 for 48h, marked morphological changes were
clearly observed, including chromatin condensation, nuclear
and cytoplasmic fragmentation, and apoptotic body appear-
ance. Further studies using PI staining and ﬂow cytometry
analysis showed that CI431 signiﬁcantly induced a G2/S8 Evidence-Based Complementary and Alternative Medicine
phase arrest with a decrease in G0/G1 phase population, and
17.3% hypodiploid cells were observed when the dose up to
60μg/mL. Considering ﬁgures of apoptosis bodies obtained
from staining with DAPI and 17.3% hypodiploid BEL-
7402 cells reserved from ﬂow cytometry, we concluded that
CI431 could induce the apoptosis of BEL-7402 cell lines. In
addition, marked mitochondrial-membrane-potential chan-
ges were clearly observed especially after treatment with
0.1mg/mL of CI431 for 24h. Loss of mitochondrial-mem-
brane potential (ΔΨm)i sa ne a r l ye v e n ti na p o p t o s i s .I t
indicated that maybe CI431 induced BEL-7402 cell apoptosis
through a mitochondria-mediated apoptosis pathway.
5. Conclusion
This study describes for the ﬁrst time an eﬃcient method
for the puriﬁcation of a kind of antitumor compound from
Ciona intestinalis L. It could eﬀectively induce apoptosis in
HCC cell lines, mediated through a disruption of mitochon-
drial membrane potential. Our results suggest that CI431
is a promising drug candidate for the treatment of HCC.
However, the speciﬁc mechanism of the apoptosis-inducing
eﬀect of CI431 has not yet been elucidated. The eﬀective and
powerfulcomponentsinthisextractedcompoundneedtobe
further characterized. Because some secondary metabolites
are generated in organisms just in a very short period of their
lifecycles,andsometargetchemicalsareinlowconcntration,
how to obtain enough chemicals for structure analyzing and
preclinical testing has become a crucial problem in marine
medicine research. In this study, the yield rate of CI431 from
Ciona intestinalis L. was extremely low. In order to elucidate
its structural formula, more samples should be collected,
isolated, and puriﬁed.
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